Abstract
In this study, Cu(II) complexes with fluorinated ligands were produced aiming at the development of new, less toxic antileishmanial metallodrugs. Complexes of the general formula CuL2 (L = lactate, trifluorolactate, 2-hydroxyisobutyrate, trifluoro-2-hydroxyisobutyrate) were synthesized in methanolic medium, purified by crystallization and characterized by elemental analysis and electronic and infrared spectroscopies. In vitro experiments with Leishmania amazonensis promastigotes showed that the trifluorolactate derivative more active than its non-fluorinated counterpart. Our results indicate that fluorinated chelators may be interesting to increase metal toxicity and/or open new paths for metallodrug chemotherapy against leishmaniasis.
Similar content being viewed by others
References
Arruda D (2005) Antileishmanial activity of the terpene nerolidol. Antimicrob Agents Chemother 49:1679–1687
Berman JD (1988) Chemotherapy for leishmaniasis–biochemical mechanisms, clinical efficacy, and future strategies. Revi Infect Dis 10:560–586
Biffinger JC, Kim HW, DiMagno SG (2004) The polar hydrophobicity of fluorinated compounds. Chembiochem 5:622–627
Bobtelsky M, Bar-Gadda I (1953) Complexes of copper with alkali salts of phthalic, malonic, succinic, maleic, salicylic, and lactic acids-constitution and properties. Bull Soc Chimique France 27:6–279
Boeck P (2006) Synthesis of chalcone analogues with increased antileishmanial activity. Bioorg Med Chem 14:1538–1545
Bohm HJ (2004) Fluorine in medicinal chemistry. Chembiochem 5:637–643
Bolard J (1965) Infrared spectra of complex salts of hydroxyacids. I. Cobalt(II)-, nickel(II)- and copper(II) salts. J Chimie Physique Physico-Chimie Biologique 62:900–907
Buravchuk YP, Sokolov VP, Kogan VA, Osipov OA, Parimski A (1974) Coordination-compounds of Divalent Cobalt, Nickel and Copper with Higher Alpha-Hydroxycarboxylic Acids. Zh Obshchei Khimii 44:1626–1630
Carballo R, Castineiras A, Covelo B, Vazquez-Lopez EM (2001) Coordination polymers of copper(II) based on mixed N- and O-donor ligands: the crystal structures of CuL2(4,4′-bipy)(n) (L = lactate or 2-methyllactate). Polyhedron 20:899–904
Croft S, Barret M, Urbina J (2005) Chemotherapy of trypanosomiases and leishmaniosis. Trends Parasitol 21:508–512
Croft SL, Sundar S, Fairlamb AH (2006) Drug resistance in leishmaniasis. Clin Microbiol Rev 19:111–126
Deacon GB, Philips RJ (1980) Relationships between the carbon-oxygen stretching frequencies of carboxylato complexes and the type of carboxylate coordination. Coord Chem Rev 33:227–250
Dillon KB, Rossotti FJ (1966) Location of binding sites for Cu(II) in carboxylate ligands by differential proton relaxation. Chem Comm 21:768–769
Engelmann FM, Mayer I, Gabrielli DS, Toma HE, Kowaltowski AJ, Araki K, Baptista MS (2007) Interaction of cationic meso-porphyrins with liposomes, mitochondria and erythrocytes. J Bioenerg Biomembr 39:175–185
Esposito BP, Faljoni-Alario A, de Menezes JFS, de Brito HF, Najjar R (1999) A circular dichroism and fluorescence quenching study of the interactions between rhodium(II) complexes and human serum albumin. J Inorg Biochem 75:55–61
Forrest JG, Prout CK, Rossotti FJ (1966) Crystal structures of copper(II) alpha-hydroxy- and alpha-alkoxy-carboxylates. Chem Comm 65:8–659
Fricker SP, Mosi RM, Cameron BR, Baird I, Zhu YB, Anastassov V, Cox J, Doyle PS, Hansell E, Lau G, Langille J, Olsen M, Qin L, Skerlj R, Wong RSY, Santucci Z, McKerrow JH (2008) Metal compounds for the treatment of parasitic diseases. J Inorg Biochem 102:1839–1845
Gerebtzoff G (2004) Halogenation of drugs enhances membrane binding and permeation. Chembiochem 5:214–231
Goulden JDS (1960) Infrared spectra of lactates in aqueous solution. Spectrochim Acta 16:715–720
Harford C, Sarkar B (1997) Amino terminal Cu(II)- and Ni(II)-binding (ATCUN) motif of proteins and peptides: metal binding, DNA cleavage, and other properties. Acc Chem Res 30:123–130
Ibrahim SA, Yang H, Seo CW (2008) Antimicrobial activity of lactic acid and copper on growth of Salmonella and Escherichia coli O157:H7 in laboratory medium and carrot juice. Food Chem 109:137–143
Khabnadideh S (2005) Design, synthesis and evaluation of 2, 4-diaminoquinazolines as inhibitors of trypanosomal and leishmanial dihydrofolate reductase. Bioorg Med Chem 13:2637–2649
Kim H (1998) Structure and transport properties of a novel, heavily fluorinated carbohydrate analogue. J Am Chem Soc 120:9082–9083
Lim CY, Yoo YH, Sidharthan M, Ma CW, Bang IC, Kim JM, Lee KS, Park NS, Shin HW (2006) Effects of copper (I) oxide on growth and biochemical compositions of two marine microalgae. J Environ Biol 27:461–466
Marsden PD (1985) Clinical presentations of Leishmania braziliensis braziliensis. Parasitol Today 1:129–133
Mohanty NK, Patnaik RK (1984) Lactate complexes of cadmium(II), zinc(II), cobalt(II), nickel(II) and copper(II). J Inst Chem (India) 56:91–94
Murray H (2005) Advances in Leishmaniasis. Lancet 366:1561–1577
Navarro M, Cisneros-Fajardo EJ, Fernandez-Mestre M, Arrieche D, Marchan E (2003a) Synthesis, characterization, DNA binding study and biological activity against Leishmania mexicana of Cu(dppz)(2)BF4. J Inorg Biochem 97:364–369
Navarro M, Cisneros-Fajardo EJ, Sierralta A, Fernandez-Mestre M, Silva P, Arrieche D, Marchan E (2003b) Design of copper DNA intercalators with leishmanicidal activity. J Biol Inorg Chem 8:401–408
Navarro M, Hernandez C, Colmenares I, Hernandez P, Fernandez M, Sierraalta A, Marchan E (2007) Synthesis and characterization of Au(dppz)(2)Cl3. DNA interaction studies and biological activity against Leishmania (L) mexicana. J Inorg Biochem 101:111–116
Prout CK, Armstron Ra, Carruthe JR, Forrest JG, Murrayru P, Rossotti FJ (1968) Structure and stability of carboxylate complexes. 1.Crystal and molecular structures of copper(2) glycollate, DL-lactate, 2-hydroxy-2-methylpropionate, methoxyacetate and phenoxyacetate. J Chem Soc A 279:1–2813
Rath S, Trivelin LA, Imbrunito TR, Tomazela DM, de Jesus MN, Marzal PC, Junior HFD, Tempone AG (2003) Antimonials employed in the treatment of leishmaniaisis: the state of the art. Quim Nova 26:550–555
Shimizu M, Hiyama T (2005) Modern synthetic methods for fluorine-substituted target molecules. Angew Chem Int Ed 44:214–231
Shriver D, Atkins P (1999) Inorganic chemistry. Oxford University Press, Oxford
Silverstein RM, Webster FX, Kiemle D (2005) Spectrometric identification of organic compounds. Wiley, New York
Souza GFP, Yokoyama-Yasunaka JKU, Seabra AB, Miguel DC, Oliveira MG, Uliana SRB (2006) Leishmanicidal activity of primary S-nitrosothiols against Leishmania major and Leishmania amazonensis: Implications for the treatment of cutaneous leishmaniasis. Nitric Oxide 15:209–216
Visbal G, Marchan E, Maldonado A, Simoni Z, Navarro M (2008) Synthesis and characterization of platinum-sterol hydrazone complexes with biological activity against Leishmania (L.) mexicana. J Inorg Biochem 102:547–554
Yan S, Jin L, Sun H (2005) 51-Sb antimony in medicine. In: Gielen M, Tiekink ERT (eds) Metallotherapeutic drugs and metal-based diagnostic agents. Wiley, New York, pp 441–461
Acknowledgments
Authors are thankful for financial support from CNPq and FAPESP (Brazilian funding agencies).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
da Silva Maffei, R., Yokoyama-Yasunaka, J.K.U., Miguel, D.C. et al. Synthesis, characterization and evaluation of antileishmanial activity of copper(II) with fluorinated α-hydroxycarboxylate ligands. Biometals 22, 1095–1101 (2009). https://doi.org/10.1007/s10534-009-9260-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10534-009-9260-1